Published in J Biol Chem on November 17, 1995
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies | NCT00703170
MAP kinase pathways in the yeast Saccharomyces cerevisiae. Microbiol Mol Biol Rev (1998) 6.20
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A (2006) 4.56
Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast. EMBO J (1999) 3.63
Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics (2011) 3.28
Rapamycin induces the G0 program of transcriptional repression in yeast by interfering with the TOR signaling pathway. Mol Cell Biol (1998) 2.91
Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol Mol Biol Rev (2002) 2.69
Using the principle of entropy maximization to infer genetic interaction networks from gene expression patterns. Proc Natl Acad Sci U S A (2006) 2.21
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci (2010) 2.15
Response and acquired resistance to everolimus in anaplastic thyroid cancer. N Engl J Med (2014) 2.09
A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR). Proc Natl Acad Sci U S A (2000) 2.04
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. Oncotarget (2012) 1.96
Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis (2001) 1.91
Rapamycin resistance tied to defective regulation of p27Kip1. Mol Cell Biol (1996) 1.89
Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans. EMBO J (2000) 1.76
The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J Physiol (2011) 1.65
Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol Cell Biol (1999) 1.64
Competition between pre-mRNAs for the splicing machinery drives global regulation of splicing. Mol Cell (2013) 1.62
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature (2016) 1.55
Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast. Mol Biol Cell (1999) 1.53
Attachment of the ubiquitin-related protein Urm1p to the antioxidant protein Ahp1p. Eukaryot Cell (2003) 1.52
Efficient Tor signaling requires a functional class C Vps protein complex in Saccharomyces cerevisiae. Genetics (2007) 1.52
Urmylation: a ubiquitin-like pathway that functions during invasive growth and budding in yeast. Mol Biol Cell (2003) 1.47
PP2A phosphatase activity is required for stress and Tor kinase regulation of yeast stress response factor Msn2p. Eukaryot Cell (2004) 1.39
Eap1p, a novel eukaryotic translation initiation factor 4E-associated protein in Saccharomyces cerevisiae. Mol Cell Biol (2000) 1.39
Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob Agents Chemother (2001) 1.37
Fission yeast TORC1 regulates phosphorylation of ribosomal S6 proteins in response to nutrients and its activity is inhibited by rapamycin. J Cell Sci (2010) 1.32
Regulation of leucine uptake by tor1+ in Schizosaccharomyces pombe is sensitive to rapamycin. Genetics (2004) 1.28
Endoplasmic reticulum and Golgi localization sequences for mammalian target of rapamycin. Mol Biol Cell (2007) 1.28
Autophagy and neurodegeneration. J Clin Invest (2015) 1.24
Receptor internalization in yeast requires the Tor2-Rho1 signaling pathway. Mol Biol Cell (2003) 1.23
Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin Microbiol Rev (1999) 1.21
Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Mol Cell Biol (2002) 1.18
mTOR pathway in colorectal cancer: an update. Oncotarget (2014) 1.15
Molecular characterization of a FKBP-type immunophilin from higher plants. Proc Natl Acad Sci U S A (1996) 1.13
Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int J Biochem Cell Biol (2011) 1.10
Roles of autophagy in cetuximab-mediated cancer therapy against EGFR. Autophagy (2010) 1.07
The Tap42-protein phosphatase type 2A catalytic subunit complex is required for cell cycle-dependent distribution of actin in yeast. Mol Cell Biol (2003) 1.03
Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity. Proc Natl Acad Sci U S A (2010) 1.03
Mechanical stimulation induces mTOR signaling via an ERK-independent mechanism: implications for a direct activation of mTOR by phosphatidic acid. PLoS One (2012) 1.03
Visualization of biochemical networks in living cells. Proc Natl Acad Sci U S A (2001) 1.00
Superoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complex. Proc Natl Acad Sci U S A (2008) 0.98
Rapamycin induces transactivation of the EGFR and increases cell survival. Oncogene (2009) 0.97
mTOR is the rapamycin-sensitive kinase that confers mechanically-induced phosphorylation of the hydrophobic motif site Thr(389) in p70(S6k). FEBS Lett (2007) 0.97
FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae. Mol Cell Biol (1997) 0.96
Bone growth during rapamycin therapy in young rats. BMC Pediatr (2009) 0.94
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors. Oncotarget (2014) 0.94
Toward rapamycin analog (rapalog)-based precision cancer therapy. Acta Pharmacol Sin (2015) 0.94
Role of the Fusarium fujikuroi TOR kinase in nitrogen regulation and secondary metabolism. Eukaryot Cell (2006) 0.94
COPI selectively drives maturation of the early Golgi. Elife (2015) 0.94
Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor. Eukaryot Cell (2011) 0.92
Functions of FKBP12 and mitochondrial cyclophilin active site residues in vitro and in vivo in Saccharomyces cerevisiae. Mol Biol Cell (1997) 0.92
Simplified cyclic analogues of bastadin-5. Structure-activity relationships for modulation of the RyR1/FKBP12 Ca2+ channel complex. J Med Chem (2006) 0.92
Conservation, duplication, and loss of the Tor signaling pathway in the fungal kingdom. BMC Genomics (2010) 0.91
A functional variomics tool for discovering drug-resistance genes and drug targets. Cell Rep (2013) 0.90
Hmo1p, a high mobility group 1/2 homolog, genetically and physically interacts with the yeast FKBP12 prolyl isomerase. Genetics (1999) 0.90
TORC1 inhibition induces lipid droplet replenishment in yeast. Mol Cell Biol (2014) 0.89
Genetic analysis of the TOR pathway in Aspergillus nidulans. Eukaryot Cell (2005) 0.84
Crosstalk between the Tor and Gcn2 pathways in response to different stresses. Cell Cycle (2013) 0.83
Conditionally controlling nuclear trafficking in yeast by chemical-induced protein dimerization. Nat Protoc (2010) 0.83
An emerging role for the Mammalian target of rapamycin in "pathological" protein translation: relevance to cocaine addiction. Front Pharmacol (2012) 0.82
Podospora anserina target of rapamycin. Curr Genet (2006) 0.81
mTOR: a potential therapeutic target in osteoarthritis? Drugs R D (2015) 0.81
Functional profiling discovers the dieldrin organochlorinated pesticide affects leucine availability in yeast. Toxicol Sci (2013) 0.80
Insights from yeast into whether the inhibition of heat shock transcription factor (Hsf1) by rapamycin can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor. Oncotarget (2014) 0.80
Physical and genetic-interaction density reveals functional organization and informs significance cutoffs in genome-wide screens. Proc Natl Acad Sci U S A (2013) 0.80
Rapid cytoplasmic turnover of yeast ribosomes in response to rapamycin inhibition of TOR. Mol Cell Biol (2012) 0.79
Conditional depletion of nuclear proteins by the Anchor Away system. Curr Protoc Mol Biol (2011) 0.79
Confirmation of the cellular targets of benomyl and rapamycin using next-generation sequencing of resistant mutants in S. cerevisiae. Mol Biosyst (2014) 0.78
Rapamycin inhibits yeast nucleotide excision repair independently of tor kinases. Toxicol Sci (2009) 0.77
Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulin-mediated intracellular signaling cascade. Int J Mol Sci (2008) 0.76
Rapid Identification of Chemoresistance Mechanisms Using Yeast DNA Mismatch Repair Mutants. G3 (Bethesda) (2015) 0.76
Reciprocal Regulation of Target of Rapamycin Complex 1 and Potassium Accumulation. J Biol Chem (2016) 0.75
Conservation of the Tsc/Rheb/TORC1/S6K/S6 Signaling in Fission Yeast. Enzymes (2015) 0.75
TORC1 kinase and the S-phase cyclin Clb5 collaborate to promote mitotic spindle assembly and DNA replication in S. cerevisiae. Curr Genet (2010) 0.75
Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity. Oxid Med Cell Longev (2017) 0.75
Disentangling genetic and epigenetic determinants of ultrafast adaptation. Mol Syst Biol (2016) 0.75
An overview of rapamycin: from discovery to future perspectives. J Ind Microbiol Biotechnol (2016) 0.75
Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction. Nat Commun (2017) 0.75
Nuclear protein localization. Biochim Biophys Acta (1991) 6.43
The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev (1999) 5.80
Signal transduction cascades regulating fungal development and virulence. Microbiol Mol Biol Rev (2000) 5.49
A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature (2001) 4.33
Cryptococcus neoformans mating and virulence are regulated by the G-protein alpha subunit GPA1 and cAMP. Genes Dev (1997) 4.28
Gene disruption with PCR products in Saccharomyces cerevisiae. Gene (1995) 4.06
Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J (1997) 3.67
Yeast pseudohyphal growth is regulated by GPA2, a G protein alpha homolog. EMBO J (1997) 3.41
Cyclic AMP-dependent protein kinase regulates pseudohyphal differentiation in Saccharomyces cerevisiae. Mol Cell Biol (1999) 3.22
Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol (2001) 3.11
The MEP2 ammonium permease regulates pseudohyphal differentiation in Saccharomyces cerevisiae. EMBO J (1998) 3.09
Site-specific methylases induce the SOS DNA repair response in Escherichia coli. J Bacteriol (1987) 2.94
Rapamycin induces the G0 program of transcriptional repression in yeast by interfering with the TOR signaling pathway. Mol Cell Biol (1998) 2.91
The TOR kinases link nutrient sensing to cell growth. J Biol Chem (2001) 2.67
Serotype AD strains of Cryptococcus neoformans are diploid or aneuploid and are heterozygous at the mating-type locus. Infect Immun (2001) 2.39
The G protein-coupled receptor gpr1 is a nutrient sensor that regulates pseudohyphal differentiation in Saccharomyces cerevisiae. Genetics (2000) 2.35
RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol Microbiol (2000) 2.30
Characterization of alcohol-induced filamentous growth in Saccharomyces cerevisiae. Mol Biol Cell (2000) 2.27
Regulators of pseudohyphal differentiation in Saccharomyces cerevisiae identified through multicopy suppressor analysis in ammonium permease mutant strains. Genetics (1998) 2.21
All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1997) 2.14
Gene disruption by biolistic transformation in serotype D strains of Cryptococcus neoformans. Fungal Genet Biol (2000) 2.06
Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO J (1994) 2.06
Conserved cAMP signaling cascades regulate fungal development and virulence. FEMS Microbiol Rev (2001) 2.04
The G-protein beta subunit GPB1 is required for mating and haploid fruiting in Cryptococcus neoformans. Mol Cell Biol (2000) 2.03
Identification of the MATa mating-type locus of Cryptococcus neoformans reveals a serotype A MATa strain thought to have been extinct. Proc Natl Acad Sci U S A (2000) 1.96
FKBP12-rapamycin target TOR2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity. EMBO J (1995) 1.94
The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery. EMBO J (2000) 1.88
Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans. Mol Microbiol (2001) 1.87
Calcineurin. Structure, function, and inhibition. Cell Biochem Biophys (1999) 1.82
Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans. EMBO J (2000) 1.76
TOR kinase homologs function in a signal transduction pathway that is conserved from yeast to mammals. Mol Cell Endocrinol (1999) 1.76
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
The STE12alpha homolog is required for haploid filamentation but largely dispensable for mating and virulence in Cryptococcus neoformans. Genetics (1999) 1.75
Calcineurin is essential in cyclosporin A- and FK506-sensitive yeast strains. Proc Natl Acad Sci U S A (1994) 1.72
Diploid strains of the pathogenic basidiomycete Cryptococcus neoformans are thermally dimorphic. Fungal Genet Biol (2000) 1.69
Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother (2000) 1.66
Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol Cell Biol (1999) 1.64
Protection from nitrosative stress by yeast flavohemoglobin. Proc Natl Acad Sci U S A (2000) 1.60
Signal transduction cascades regulating pseudohyphal differentiation of Saccharomyces cerevisiae. Curr Opin Microbiol (2000) 1.60
Sok2 regulates yeast pseudohyphal differentiation via a transcription factor cascade that regulates cell-cell adhesion. Mol Cell Biol (2000) 1.57
Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase. EMBO J (2000) 1.54
The TOR signal transduction cascade controls cellular differentiation in response to nutrients. Mol Biol Cell (2001) 1.53
Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast. Mol Biol Cell (1999) 1.53
Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. EMBO J (1995) 1.47
Comparison of the roles of calcineurin in physiology and virulence in serotype D and serotype A strains of Cryptococcus neoformans. Infect Immun (2000) 1.46
Two cyclophilin A homologs with shared and distinct functions important for growth and virulence of Cryptococcus neoformans. EMBO Rep (2001) 1.46
Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans. EMBO J (2001) 1.45
Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin. Antimicrob Agents Chemother (2000) 1.42
Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil. J Clin Microbiol (2004) 1.41
Signal transduction pathways regulating differentiation and pathogenicity of Cryptococcus neoformans. Fungal Genet Biol (1998) 1.41
Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob Agents Chemother (2001) 1.37
Morphogenesis of Cryptococcus neoformans. Contrib Microbiol (2000) 1.34
CNS1 encodes an essential p60/Sti1 homolog in Saccharomyces cerevisiae that suppresses cyclophilin 40 mutations and interacts with Hsp90. Mol Cell Biol (1998) 1.30
Signal transduction cascades regulating mating, filamentation, and virulence in Cryptococcus neoformans. Curr Opin Microbiol (1999) 1.27
Characterization of the MFalpha pheromone of the human fungal pathogen cryptococcus neoformans. Mol Microbiol (2000) 1.27
Sphingolipids signal heat stress-induced ubiquitin-dependent proteolysis. J Biol Chem (2000) 1.26
STT4 is an essential phosphatidylinositol 4-kinase that is a target of wortmannin in Saccharomyces cerevisiae. J Biol Chem (1997) 1.26
vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H(+)-ATPase assembly. Genetics (1995) 1.24
The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother (1997) 1.24
A yeast cyclophilin gene essential for lactate metabolism at high temperature. Proc Natl Acad Sci U S A (1992) 1.23
Cryptococcus neoformans differential gene expression detected in vitro and in vivo with green fluorescent protein. Infect Immun (1999) 1.22
Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin Microbiol Rev (1999) 1.21
A STE12 homolog is required for mating but dispensable for filamentation in candida lusitaniae. Genetics (2000) 1.19
Signal-transduction cascades as targets for therapeutic intervention by natural products. Trends Biotechnol (1998) 1.19
Molecular analysis of the Cryptococcus neoformans ADE2 gene, a selectable marker for transformation and gene disruption. Fungal Genet Biol (1999) 1.18
Topoisomerase I is essential in Cryptococcus neoformans: role In pathobiology and as an antifungal target. Genetics (1999) 1.15
Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast. Genes Dev (1996) 1.14
Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. Biochem Biophys Res Commun (1997) 1.13
Phytosphingosine as a specific inhibitor of growth and nutrient import in Saccharomyces cerevisiae. J Biol Chem (2001) 1.12
Immunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast. J Biol Chem (1996) 1.06
Nomenclature relating to restriction of modified DNA in Escherichia coli. J Bacteriol (1991) 1.03
Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. Microbiology (1999) 0.99
A new face of the Rhesus antigen. Nat Genet (2000) 0.97
FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae. Mol Cell Biol (1997) 0.96
Mutations that perturb cyclophilin A ligand binding pocket confer cyclosporin A resistance in Saccharomyces cerevisiae. J Biol Chem (1995) 0.96
Myristoylation of calcineurin B is not required for function or interaction with immunophilin-immunosuppressant complexes in the yeast Saccharomyces cerevisiae. J Biol Chem (1995) 0.95
Isolation of Cryptococcus gattii and Cryptococcus neoformans var. grubii from the flowers and bark of Eucalyptus trees in India. Med Mycol (2005) 0.94
Nitrosative stress: protection by glutathione-dependent formaldehyde dehydrogenase. Redox Rep (2001) 0.93
Functions of FKBP12 and mitochondrial cyclophilin active site residues in vitro and in vivo in Saccharomyces cerevisiae. Mol Biol Cell (1997) 0.92
Calcineurin mutants render T lymphocytes resistant to cyclosporin A. Mol Pharmacol (1996) 0.92
Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. Curr Opin Nephrol Hypertens (1995) 0.91
Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells. Antimicrob Agents Chemother (1999) 0.90
Hmo1p, a high mobility group 1/2 homolog, genetically and physically interacts with the yeast FKBP12 prolyl isomerase. Genetics (1999) 0.90
Regional bivalent-univalent pairing versus trivalent pairing of a trisomic chromosome in Saccharomyces cerevisiae. Genetics (1996) 0.90
Tn5-mediated bleomycin resistance in Escherichia coli requires the expression of host genes. Mol Microbiol (1993) 0.88
Quantitation of residual white cells in filtered blood components by polymerase chain reaction amplification of HLA DQ-A DNA. Transfusion (1994) 0.87
FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes. Cell Growth Differ (1998) 0.84
Role of calcium in T-lymphocyte activation. Adv Second Messenger Phosphoprotein Res (1995) 0.83
Proline isomerases in microorganisms and small eukaryotes. Ann N Y Acad Sci (1993) 0.83
Saturation mutagenesis of His114 of EcoRI reveals relaxed-specificity mutants. Gene (1995) 0.82
Cyclophilin active site mutants have native prolyl isomerase activity with a protein substrate. FEBS Lett (1997) 0.82
Mutational analysis of the function of Met137 and Ile197, two amino acids implicated in sequence-specific DNA recognition by the EcoRI endonuclease. Biol Chem (1998) 0.82
Lic4, a nuclear phosphoprotein that cooperates with calcineurin to regulate cation homeostasis in Saccharomyces cerevisiae. Mol Gen Genet (1999) 0.80
R73A and H144Q mutants of the yeast mitochondrial cyclophilin Cpr3 exhibit a low prolyl isomerase activity in both peptide and protein-folding assays. FEBS Lett (1999) 0.79
Molecular cloning and characterization of Aspergillus nidulans cyclophilin B. Fungal Genet Biol (1999) 0.79
It infects me, it infects me not: phenotypic switching in the fungal pathogen Cryptococcus neoformans. J Clin Invest (2001) 0.79
Temperature-sensitive mutants of the EcoRI endonuclease. J Mol Biol (1997) 0.79
Human immunodeficiency virus. Chaperoning a pathogen. Nature (1994) 0.78